Tag Archives: age-related macular degeneration

November, 2018

August, 2018

July, 2018

August, 2017

June, 2017

February, 2017

October, 2016

  • 17 October

    FDA Approves Genentech’s Lucentis Prefilled Syringe

    SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved the Lucentis® (ranibizumab injection) 0.5 mg prefilled syringe (PFS) as a new method of administering the medicine. Like the Lucentis 0.5 mg vial, …

  • 13 October

    Ocular Therapeutix and Regeneron Collaborate for Development of New Eylea Formulation

    BEDFORD, Mass–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it has entered into a strategic collaboration, option and license agreement with Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Ocular and Regeneron will …

August, 2016

March, 2016